Phathom Pharmaceuticals Inc (PHAT) Event Aug. 02, 2022, 00:00 UTC (61% Neutral) PHATHOM PHARMACEUTICALS, INC. (PHAT) Reports Net Loss for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 10:29 a.m. 🏢 Phathom Pharmaceuticals Inc (PHAT) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-02 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-36.55M $-36.55M N/A +0.00% ➡️ Total Assets $189.43M $213.50M $-24.07M -11.27% 📉 Total Liabilities $117.28M $220.50M $-103.23M -46.81% 📈 Stockholders' Equity $132.13M $-456.88M $589.01M +128.92% 📈 Operating Income/Loss $-68.90M $-83.27M $14.37M +17.25% 📉 R&D Expense $42.18M $36.48M $5.70M +15.64% 📉 Earningspersharebasic $-1.96 $-2.40 $0.44 +18.33% 📈 Earningspersharediluted $-1.96 $-2.40 $0.44 +18.33% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Phathom Pharmaceuticals Inc (PHAT) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document